Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bocun Yi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
BMC Cancer|April 11, 2024
ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validationYue Huang, Dapeng Chen, Yi Bai, et al.
Environmental Pollution (Barking, Essex : 1987)|May 14, 2023
Low-dose graphene oxide promotes tumor cells proliferation by activating PI3K-AKT-mTOR signaling via cellular membrane protein integrin αVZhiwen Zheng, Abuduliaizezi Halifu, Juan Ma, et al.
Frontiers in Oncology|June 30, 2023
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapyHongtuan Zhang, Dongze Liu, Zheng Qin, et al.
Aging|December 26, 2023
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancerShengxian Xu, Dongze Liu, Zheng Qin, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
BMC Cancer|April 11, 2024
ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validationYue Huang, Dapeng Chen, Yi Bai, et al.
Environmental Pollution (Barking, Essex : 1987)|May 14, 2023
Low-dose graphene oxide promotes tumor cells proliferation by activating PI3K-AKT-mTOR signaling via cellular membrane protein integrin αVZhiwen Zheng, Abuduliaizezi Halifu, Juan Ma, et al.
Frontiers in Oncology|June 30, 2023
CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapyHongtuan Zhang, Dongze Liu, Zheng Qin, et al.
Aging|December 26, 2023
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancerShengxian Xu, Dongze Liu, Zheng Qin, et al.
Pageof 2